Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.34 |
| ▸ | LDHB | P07195 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.33 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26797236 | 0.92 | CYP3A4 (0.48) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL5838924 | 0.89 | CYP3A4 (0.47) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL25567649 | 0.86 | CYP3A4 (0.43) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL27241390 | 0.82 | CYP3A4 (0.46) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL30932977 | 0.82 | CYP3A4 (0.46) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL11893177 | 0.82 | CYP3A4 (0.46) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL10607894 | 0.80 | CYP3A4 (0.48) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL9752724 | 0.80 | CYP3A4 (0.48) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL19149846 | 0.78 | CYP3A4 (0.48) | CYP3A4CYP1A2MEN1KMT2ATHRB | |
| SCHEMBL16475964 | 0.78 | LDHA (0.34) | CYP3A4LDHALDHBPLA2G2APLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240032421-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | UDC IRELAND LIMITED (IE) | 2024-01-25 | — | — | US | disclosed |
| US-11800798-B2 | Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device | UDC IRELAND LIMITED (IE) | 2023-10-24 | — | — | US | disclosed |
| US-20180145264-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | UDC IRELAND LTD (IE) | 2018-05-24 | — | — | US | disclosed |
| US-9887371-B2 | Organic electroluminescent device; a charge transporting material for the organic electroluminescent device; and a luminescent device, a display device and a lighting system using the organic electroluminescent device | UDC IRELAND LIMITED (IE) | 2018-02-06 | — | — | US | disclosed |
| US-20160260910-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | UDC IRELAND LTD (IE) | 2016-09-08 | — | — | US | disclosed |
| US-9328205-B2 | Iron(III) containing complex and condensation reaction catalysts, methods for preparing the catalysts, and compositions containing the catalysts | DOW CORNING CORPORATION (US) | 2016-05-03 | — | — | US | disclosed |
| US-9306176-B2 | Organic electroluminescent device; a charge transporting material for the organic electroluminescent device; and a luminescent device, a display device and a lighting system using the organic electroluminescent device | UDC IRELAND LIMITED (IE) | 2016-04-05 | — | — | US | disclosed |
| US-9000421-B2 | Organic electroluminescent element, materials for organic electroluminescent element, and light emitting device, display device, or illumination device, each using the element, and compounds used in the element | UDC IRELAND LIMITED (IE) | 2015-04-07 | — | — | US | disclosed |
| US-20140371056-A1 | Iron(III) Containing Complex and Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts | DOW COMING CORPORATION (US) | 2014-12-18 | — | — | US | disclosed |
| US-20140034914-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | UDC IRELAND LIMITED (IE) | 2014-02-06 | — | — | US | disclosed |
| EP-0277836-B1 | THIAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR USE | Sankyo Company Limited (JP) | 1993-06-02 | — | — | EP | disclosed |
| US-4873255-A | REDUCE BLOOD GLUCOSE AND BLOOD LIPID LEVELS | SANKYO COMPANY LIMITED (JP) | 1989-10-10 | — | — | US | disclosed |
| EP-0277836-A1 | Thiazolidinone derivatives, their preparation and their use | Sankyo Company Limited (JP) | 1988-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145264-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | SLC43A1, SLC6A19, AOC3 | CYP3A4 595/4885CYP1A2 484/4885MEN1 3233/4885 |
| US-11800798-B2 | Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device | TMEM109, SLC39A11, SLC39A14 | CYP3A4 2956/4885CYP1A2 2454/4885MEN1 1647/4885 |
| US-20240032421-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | TMEM109, SLC39A11, SLC39A14 | CYP3A4 2956/4885CYP1A2 2454/4885MEN1 1647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.